 GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 08, 2022 GLOBE NEWSWIRE -- Applied Genetic Technologies Corporation Nasdaq: AGTC, a clinical stage biotechnology company focused on the development and commercialization of adeno-associated virus AAV-based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal diseases IRDs, today announced that management will be participating in the following virtual investor conferences: 